Literature DB >> 21514014

Thiazolylmethyl ortho-substituted phenyl glucoside library as novel C-aryl glucoside SGLT2 inhibitors.

Suk Ho Lee1, Min Ju Kim, Sung-Han Lee, Jeongmin Kim, Hyun-Ju Park, Jinhwa Lee.   

Abstract

In order to investigate SAR regarding proximal phenyl ring in novel C-aryl glucoside SGLT2 inhibitors containing a thiazole motif, a series of chemical modifications on proximal phenyl ring was conducted. During a series of lead optimization efforts, ortho-allyloxyphenyl 10p or ortho-hydroxyphenyl 11a showed subnanomolar inhibitory activity against hSGLT2.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514014     DOI: 10.1016/j.ejmech.2011.03.052

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  A specific pharmacophore model of sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

Authors:  Chunlei Tang; Xiaoyun Zhu; Dandan Huang; Xin Zan; Baowei Yang; Ying Li; Xiaoyong Du; Hai Qian; Wenlong Huang
Journal:  J Mol Model       Date:  2011-11-27       Impact factor: 1.810

2.  Cytotoxic 1,3-Thiazole and 1,2,4-Thiadiazole Alkaloids from Penicillium oxalicum: Structural Elucidation and Total Synthesis.

Authors:  Zheng Yang; Nianyu Huang; Bang Xu; Wenfeng Huang; Tianpeng Xie; Fan Cheng; Kun Zou
Journal:  Molecules       Date:  2016-02-26       Impact factor: 4.411

3.  Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors.

Authors:  Ádám Sipos; Eszter Szennyes; Nikolett Éva Hajnal; Sándor Kun; Katalin E Szabó; Karen Uray; László Somsák; Tibor Docsa; Éva Bokor
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-15

Review 4.  SGLT inhibitors as antidiabetic agents: a comprehensive review.

Authors:  Rahul P Kshirsagar; Abhishek A Kulkarni; Rashmi S Chouthe; Shahebaaz K Pathan; Hemant D Une; G Bhanuprakash Reddy; Prakash V Diwan; Siddique Akber Ansari; Jaiprakash N Sangshetti
Journal:  RSC Adv       Date:  2020-01-09       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.